3-(2,6-二氯苯基)-4-(3'-羧基-2-氯二苯乙烯-4-基)氧甲基-5-异丙基异恶唑
中文名称 | 3-(2,6-二氯苯基)-4-(3'-羧基-2-氯二苯乙烯-4-基)氧甲基-5-异丙基异恶唑 |
---|---|
中文同义词 | 3-(2,6-二氯苯基)-4-(3'-羧基-2-氯二苯乙烯-4-基)氧甲基-5-异丙基异恶唑;3-[2-氯-4-[[3-(2,6-二氯苯基)-5-异丙基-4-异噁唑基]甲氧基]苯乙烯基]苯甲酸;3-(2-氯-4-((3-(2,6-二氯苯基)-5-异丙基异恶唑-4-基)甲氧基)苯乙烯基)苯甲酸;GW4064,法尼醇X受体(FXR)激动剂;GW4067中间体;3-(2,6-二氯苯基)-4-(3'-羧基-2-氯二苯乙烯-4-基)氧甲基-5-异丙基异恶唑 |
英文名称 | GW 4064 |
英文同义词 | GW 4064;Benzoic acid, 3-[2-[2-chloro-4-[[3-(2,6-dichlorophenyl)-5-(1-methylethyl)-4-isoxazolyl]methoxy]phenyl]ethenyl]-GW 4064;3-[2-[2-Chloro-4-[[3-(2,6-Dichlorophenyl)-5-(1-methylethyl)-4-isoxazolyl]methoxy]phenyl]ethenyl]-benzoic Acid;3-(2,6-Dichlorophenyl)-4-(3'-carboxy-2-chlorostilben-4-yl)oxymethyl-5-isopropylisoxazole;3-[2-[2-Chloro-4-[[3-(2,6-dichlorophenyl)-5-isopropylisoxazol-4-yl]Methoxy]phenyl]vinyl]benzoic acid;Benzoic acid, 3-[2-[2-chloro-4-[[3-(2,6-dichlorophenyl)-5-(1-Methylethyl)-4-isoxazolyl]Methoxy]phenyl]ethenyl]-;GW-4064,3-[2-[2-Chloro-4-[3-(2,6-dichlorophenyl)-5-isopropylisoxazol-4-ylMethoxy]phenyl]vinyl]benzoi;3-[2-[2-Chloro-4-[3-(2,6-dichlorophenyl)-5-isopropyl-isoxazol-4-ylMethoxy]phenyl]vinyl]benzoic |
CAS号 | 278779-30-9 |
分子式 | C28H22Cl3NO4 |
分子量 | 542.84 |
EINECS号 | |
相关类别 | 信号转导通路激酶抑制剂;小分子抑制剂;小分子抑制剂,天然产物;其他生化试剂;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;API |
Mol文件 | 278779-30-9.mol |
结构式 |
3-(2,6-二氯苯基)-4-(3'-羧基-2-氯二苯乙烯-4-基)氧甲基-5-异丙基异恶唑 性质
熔点 | >175°C (dec.) |
---|---|
沸点 | 702.1±60.0 °C(Predicted) |
密度 | 1.367±0.06 g/cm3(Predicted) |
储存条件 | 2-8°C |
溶解度 | DMSO:可溶10mg/mL,澄清 |
酸度系数(pKa) | 4.13±0.10(Predicted) |
形态 | 粉末 |
颜色 | 白色 |
GW4064是一种farnesoid X receptor (FXR)激动剂,CV1细胞系中EC50为65 nM。浓度达到1 μM时,对其他核受体没有活性。GW4064在MCF-7细胞中可刺激自噬。
GW-4064 is a selective agonist of FXR(EC50=15 nM). It displays no activity at other nuclear receptors, including the retinoic acid receptor, at concentrations up to 1 μM. GW-4064 upregulates adipokine expression in preadipocytes and HepG2 cells. GW4064 could reduce induction of proinflammatory cytokines by LPS in vitro.
Target | Value |
FXR
(CV1) | 65 nM(EC50) |
GW 4064是一种完全激动剂,在转染有鼠源和人源FXR表达载体以及确定的报告基因的CV-1细胞中, EC50分别为80和90。GW 4064直到1 μM浓度对其它核受体也没有活性,包括维甲酸受体。因此, GW 4064是一种强有效和选择性的非类固醇FXR激动剂。
大鼠体内药代动力学实验显示GW 4064口服生物利用度为10%,t 1/2 = 3.5小时。 Fisher大鼠按剂量填喂给药。7天之后, GW 4064处理的大鼠血清甘油三酯下降并具有剂量依赖特性,ED50 = 20 mg/kg。用途
一种有效的FXR激动剂,EC50:65nM。GW-4064 is a selective agonist of FXR(EC50=15 nM). It displays no activity at other nuclear receptors, including the retinoic acid receptor, at concentrations up to 1 μM. GW-4064 upregulates adipokine expression in preadipocytes and HepG2 cells. GW4064 could reduce induction of proinflammatory cytokines by LPS in vitro.
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024/04/30 | HY-50108 | 3-(2,6-二氯苯基)-4-(3'-羧基-2-氯二苯乙烯-4-基)氧甲基-5-异丙基异恶唑 GW 4064 | 278779-30-9 | 5mg | 515元 |
2024/04/30 | S2782 | 3-(2,6-二氯苯基)-4-(3'-羧基-2-氯二苯乙烯-4-基)氧甲基-5-异丙基异恶唑 GW4064 | 278779-30-9 | 5mg | 571.57元 |